| For: | Joshi P, Middleton J, Jeon YJ, Garofalo M. MicroRNAs in lung cancer. World J Methodol 2014; 4(2): 59-72 [PMID: 25332906 DOI: 10.5662/wjm.v4.i2.59] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v4/i2/59.htm |
| Number | Citing Articles |
| 1 |
Lie Huang, Xiaomei Fu, Aipeng Liu, Meile Cheng, Xi Xu. Diagnostic potential of serum miR-197 and IL-18 levels in predicting bronchopulmonary dysplasia: a prospective cohort study. BMC Pediatrics 2026; 26(1) doi: 10.1186/s12887-026-06580-5
|
| 2 |
Wenhui Yang, Chengcheng Zhou, Mei Luo, Xuejiao Shi, Yuan Li, Zengmiao Sun, Fang Zhou, Zhaoli Chen, Jie He. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1. Oncotarget 2016; 7(13) doi: 10.18632/oncotarget.7697
|
| 3 |
Ismini Lasithiotaki, Eliza Tsitoura, Anastasios Koutsopoulos, Eleni Lagoudaki, Chara Koutoulaki, George Pitsidianakis, Demetrios A. Spandidos, Nikolaos M. Siafakas, George Sourvinos, Katerina M. Antoniou. Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer. Oncotarget 2017; 8(68) doi: 10.18632/oncotarget.11222
|
| 4 |
Tao He, Hongyou Shen, Shuangmiao Wang, Yanfang Wang, Zhiwei He, Litong Zhu, Xinyue Du, Dan Wang, Jiao Li, Shizhen Zhong, Wenhua Huang, Huiling Yang. MicroRNA-3613-5p Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop. Molecular Therapy Nucleic Acids 2020; 22 doi: 10.1016/j.omtn.2020.09.024
|
| 5 |
Mohini Kalra, Umesh Kumar. Epigenetic Therapy by Phytochemicals in Lung Cancer. 2026; doi: 10.1016/B978-0-443-45146-1.00009-6
|
| 6 |
Di Chen, Weijie Guo, Zhaoping Qiu, Qifeng Wang, Yan Li, Linhui Liang, Li Liu, Shenglin Huang, Yingjun Zhao, Xianghuo He. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Cancer Letters 2015; 362(2) doi: 10.1016/j.canlet.2015.03.041
|
| 7 |
Ji-Yong Ma, Hai-Jun Yan, Zhen-Hua Yang, Wei Gu. Rs895819 within miR-27a Might be Involved in Development of Non Small Cell Lung Cancer in the Chinese Han Population. Asian Pacific Journal of Cancer Prevention 2015; 16(5) doi: 10.7314/APJCP.2015.16.5.1939
|
| 8 |
Alberto Izzotti, Gabriela Coronel Vargas, Alessandra Pulliero, Simona Coco, Cristina Colarossi, Giuseppina Blanco, Antonella Agodi, Martina Barchitta, Andrea Maugeri, Gea Oliveri Conti, Margherita Ferrante, Salvatore Sciacca. Identification by MicroRNA Analysis of Environmental Risk Factors Bearing Pathogenic Relevance in Non-Smoker Lung Cancer. Journal of Personalized Medicine 2021; 11(7) doi: 10.3390/jpm11070666
|
| 9 |
Haijian Wu, Yan Liu, Xiao Ou Shu, Qiuyin Cai. MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targetingTGFAgene expression. Carcinogenesis 2016; 37(6) doi: 10.1093/carcin/bgw038
|
| 10 |
Mingjiu Chen, Weilin Peng, Shifeng Hu, Jie Deng. miR‑126/VCAM‑1 regulation by naringin suppresses cell growth of human non‑small cell lung cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9204
|
| 11 |
Oronzo Brunetti, Antonio Russo, Aldo Scarpa, Daniele Santini, Michele Reni, Alessandro Bittoni, Amalia Azzariti, Giuseppe Aprile, Sabina Delcuratolo, Michele Signorile, Antonio Gnoni, Loredana Palermo, Vito Lorusso, Stefano Cascinu, Nicola Silvestris. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?. Oncotarget 2015; 6(27) doi: 10.18632/oncotarget.4492
|
| 12 |
Mariana Magalhães, Carmen Alvarez-Lorenzo, Angel Concheiro, Ana Figueiras, Ana Cláudia Santos, Francisco Veiga. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opinion on Drug Delivery 2018; 15(10) doi: 10.1080/17425247.2018.1517744
|
| 13 |
O. A. Patutina, S. K. Miroshnichenko, A. A. Lomzov, N. L. Mironova, M. A. Zenkova. Search for oligonucleotides selectively binding oncogenic miR-21. Russian Journal of Bioorganic Chemistry 2017; 43(1) doi: 10.1134/S106816201701006X
|
| 14 |
Naiara C. Cinegaglia, Sonia Cristina S. Andrade, Tomas Tokar, Maísa Pinheiro, Fábio E. Severino, Rogério A. Oliveira, Erica N. Hasimoto, Daniele C. Cataneo, Antônio J.M. Cataneo, Júlio Defaveri, Cristiano P. Souza, Márcia M.C. Marques, Robson F. Carvalho, Luiz L. Coutinho, Jefferson L. Gross, Silvia R. Rogatto, Wan L. Lam, Igor Jurisica, Patricia P. Reis. Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma. Oncotarget 2016; 7(20) doi: 10.18632/oncotarget.8713
|
| 15 |
A. A. Shikeeva, T. V. Kekeeva, L. E. Zavalishina, Yu. Yu. Andreeva, D. V. Zaletaev, G. A. Frank. Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer. Arkhiv patologii 2016; 78(3) doi: 10.17116/patol20167833-10
|
| 16 |
Ping Xue, Guopei Zhang, Hongchao Zhang, Su Cui, Liang Zhang, Tao Yu, Mingyang Xiao, Liuli Li, Xiaobo Lu. A miR‐15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum‐based chemotherapy. Journal of Cellular and Molecular Medicine 2022; 26(21) doi: 10.1111/jcmm.17566
|
| 17 |
Rui Zhang, Yong Zhang, He Li. Retracted: miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma. DNA and Cell Biology 2015; 34(11) doi: 10.1089/dna.2015.2915
|
| 18 |
Yun Teng, Jingyao Mu, Xin Hu, Abhilash Samykutty, Xiaoying Zhuang, Zhongbin Deng, Lifeng Zhang, Pengxiao Cao, Jun Yan, Donald Miller, Huang-Ge Zhang. Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages. Oncotarget 2016; 7(18) doi: 10.18632/oncotarget.8361
|
| 19 |
Donya Shaterabadi, Maryam Zamani Sani, Fereshteh Rahdan, Mohammad Taghizadeh, Maedeh Rafiee, Nafiseh Dorosti, Aria Dianatinasab, Mortaza Taheri-Anganeh, Peyman Asadi, Seyyed Hossein Khatami, Ahmad Movahedpour. MicroRNA biosensors in lung cancer. Clinica Chimica Acta 2024; 552 doi: 10.1016/j.cca.2023.117676
|
| 20 |
Jian Zhang, Xiao-Hua Yu, Yi-Guo Yan, Cheng Wang, Wen-Jun Wang. PI3K/Akt signaling in osteosarcoma. Clinica Chimica Acta 2015; 444 doi: 10.1016/j.cca.2014.12.041
|
| 21 |
Weiwen Chen, Shuai Chu, Haixia Li, Yurong Qiu. MicroRNA‑146a‑5p enhances ginsenoside Rh2‑induced anti‑proliferation and the apoptosis of the human liver cancer cell line HepG2. Oncology Letters 2018; doi: 10.3892/ol.2018.9235
|
| 22 |
Ming-fan Ye, Ji-guang Zhang, Tian-xing Guo, Xiao-jie Pan. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer. Biomedicine & Pharmacotherapy 2018; 97 doi: 10.1016/j.biopha.2017.11.005
|
| 23 |
Yi Zheng, Linxia Wu, Jie Gao, Yanfu Wang. Tumor suppressive role of miR-569 in lung cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.7869
|
| 24 |
Wei Gu. Expression and Significance of Circulating MicroRNA-31 in Lung Cancer Patients. Medical Science Monitor 2015; 21 doi: 10.12659/MSM.893213
|
| 25 |
YUJIAO XING, JIANHUA FU, HAIPING YANG, LI YAO, LIN QIAO, YANNA DU, XINDONG XUE. MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia. International Journal of Molecular Medicine 2015; 36(5) doi: 10.3892/ijmm.2015.2347
|
| 26 |
Laura Boldrini, Mirella Giordano, Franca Melfi, Marco Lucchi, Gabriella Fontanini. Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. Pathology & Oncology Research 2020; 26(2) doi: 10.1007/s12253-019-00664-7
|
| 27 |
Kentaro Inamura, Yuichi Ishikawa. MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment. Journal of Clinical Medicine 2016; 5(3) doi: 10.3390/jcm5030036
|
| 28 |
David E. Midthun. Early detection of lung cancer. F1000Research 2016; 5 doi: 10.12688/f1000research.7313.1
|
| 29 |
Vildan Bozok Çetintaş, Aslı Tetik Vardarlı, Zekeriya Düzgün, Burçin Tezcanlı Kaymaz, Eda Açıkgöz, Hüseyin Aktuğ, Buket Kosova Can, Cumhur Gündüz, Zuhal Eroğlu. miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells. Tumor Biology 2016; 37(2) doi: 10.1007/s13277-015-3950-9
|
| 30 |
Tianze Zhang, Yingying Hu, Jin Ju, Liangyu Hou, Zhange Li, Dan Xiao, Yongchao Li, Jianyu Yao, Chao Wang, Yong Zhang, Linyou Zhang. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D. Scientific Reports 2016; 6(1) doi: 10.1038/srep19346
|
| 31 |
Yusuf Tutar, Aykut Özgür, Esen Tutar, Lütfi Tutar, Alessandra Pulliero, Alberto Izzotti. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer. Biomedicine & Pharmacotherapy 2016; 83 doi: 10.1016/j.biopha.2016.08.043
|
| 32 |
Jing-Yu Pan, Cheng-Cao Sun, Zhuo-Yue Bi, Zhen-Long Chen, Shu-Jun Li, Qing-Qun Li, Yu-Xuan Wang, Yong-Yi Bi, De-Jia Li. miR-206/133b Cluster: A Weapon against Lung Cancer?. Molecular Therapy - Nucleic Acids 2017; 8 doi: 10.1016/j.omtn.2017.06.002
|
| 33 |
Lidong Zu, Yunjing Xue, Jinglong Wang, Yujie Fu, Xiumin Wang, Gang Xiao, Mingang Hao, Xueqing Sun, Yingying Wang, Guohui Fu, Jianhua Wang. The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis. Carcinogenesis 2016; 37(3) doi: 10.1093/carcin/bgw011
|
| 34 |
Shuliang Liu, Xingping Ge, Lingfei Su, Aifeng Zhang, Xuri Mou. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8350
|
| 35 |
Melih Dağdeviren, Günnur Güler, Egemen Erdem Güler, Cemal Ün, Nefise Ülkü Karabay-Yavaşoğlu. Effect of miRNA administration on non-small cell lung cancer cells studied by cellular viability assay and ATR-FTIR spectroscopy combined with multivariate data-analysis. Microchemical Journal 2025; 209 doi: 10.1016/j.microc.2025.112681
|
| 36 |
Seong‐Lan Yu, Dong Chul Lee, Hyun Ahm Sohn, Soo Young Lee, Hyo Sung Jeon, Joon H. Lee, Chang Gyo Park, Hoi Young Lee, Young Il Yeom, Ji Woong Son, Yoo Sang Yoon, Jaeku Kang. Homeobox A9 directly targeted by miR‐196b regulates aggressiveness through nuclear Factor‐kappa B activity in non‐small cell lung cancer cells. Molecular Carcinogenesis 2016; 55(12) doi: 10.1002/mc.22439
|
| 37 |
Momchil Barbolov, Svetla Slavova, Neda Nedeva, Krasimir Ivanov, Nikola Kolev, Katarzyna Komosinska-Vassev, Diana Ivanova, Deyana Vankova, Yoana Kiselova-Kaneva. Dysregulated miRNAs Targeting Adiponectin Signaling in Colorectal Cancer. International Journal of Molecular Sciences 2025; 26(15) doi: 10.3390/ijms26157196
|
| 38 |
M. Krutakova, M. Sarlinova, T. Matakova, A. Dzian, J. Hamzik, M. Pec, S. Javorkova, E. Halasova. Advances in Respiratory Cancerogenesis. Advances in Experimental Medicine and Biology 2016; 911 doi: 10.1007/5584_2016_219
|
| 39 |
Ramona G. Dumitrescu. Cancer Epigenetics for Precision Medicine. Methods in Molecular Biology 2018; 1856 doi: 10.1007/978-1-4939-8751-1_1
|
| 40 |
Xi Yu, Hong Zheng, Rongfei Sun, Xuejiao Qian, Ping Jiang, Bo Yang, Jiangbo Liu, Xiaoping Li. MicroRNA-425-5p Inhibits Lung Cancer Cell Growth in Vitro and in Vivo by Downregulating TFIIB-Related Factor 2. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033819901115
|
| 41 |
Jing-Jing Liang, Jun-Yi Wang, Tong-Jia Zhang, Guo-Shun An, Ju-Hua Ni, Shu-Yan Li, Hong-Ti Jia. MiR-509-3-5p-NONHSAT112228.2 Axis Regulates p21 and Suppresses Proliferation and Migration of Lung Cancer Cells. Current Topics in Medicinal Chemistry 2020; 20(10) doi: 10.2174/1568026620666200306102713
|
| 42 |
Marco Tomasetti, Monica Amati, Jiri Neuzil, Lory Santarelli. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy. Lung Cancer 2017; 107 doi: 10.1016/j.lungcan.2016.05.023
|
| 43 |
Zoltán Nagy, Peter Igaz. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum 2015; 106 doi: 10.1007/978-3-0348-0955-9_1
|
| 44 |
Benjamin Yeung, Jihang Yu, Xiaolong Yang. Roles of the Hippo pathway in lung development and tumorigenesis. International Journal of Cancer 2016; 138(3) doi: 10.1002/ijc.29457
|
| 45 |
Srivatsava Naidu, Michela Garofalo. microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance. Frontiers in Medicine 2015; 2 doi: 10.3389/fmed.2015.00077
|
| 46 |
Rajib Kumar Dutta, Srinivasan Chinnapaiyan, Hoshang Unwalla. Aberrant MicroRNAomics in Pulmonary Complications: Implications in Lung Health and Diseases. Molecular Therapy Nucleic Acids 2019; 18 doi: 10.1016/j.omtn.2019.09.007
|
| 47 |
Amirbahador Abbasifarid, Ruhollah Dorostkar, Majdedin Ghalavand. miR-122 shows potential as a biomarker and therapeutic target in NSCLC by inhibiting WNT/β-catenin and PI3K/AKT pathways and key transcription factors linked to EMT and metastasis. Heliyon 2025; 11(6) doi: 10.1016/j.heliyon.2025.e42961
|
| 48 |
Tao Fan, Wei Wang, Boyou Zhang, Yao Xu, Lei Chen, Shize Pan, Hao Hu, Qing Geng. Regulatory mechanisms of microRNAs in lung cancer stem cells. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3425-5
|
| 49 |
Early detection of lung cancer biomarkers through biosensor technology: A review. Journal of Pharmaceutical and Biomedical Analysis 2019; 164 doi: 10.1016/j.jpba.2018.10.017
|
| 50 |
Surya Kant Tripathi, Kamal Pandey, Munmun Panda, Bijesh K. Biswal. AGO-Driven Non-Coding RNAs. 2019; doi: 10.1016/B978-0-12-815669-8.00011-7
|